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Abstract
Background: Hypochondriasis is prevalent in primary care, but the diagnosis is hampered by its stigmatizing label and lack
of valid diagnostic criteria. Recently, new empirically established criteria for Health anxiety were introduced. Little is known
about Health anxiety’s impact on longitudinal outcome, and this study aimed to examine impact on self-rated health and
health care costs.
Methodology/Principal Findings: 1785 consecutive primary care patients aged 18–65 consulting their family physicians
(FPs) for a new illness were followed-up for two years. A stratified subsample of 701 patients was assessed by the Schedules
for Clinical Assessment in Neuropsychiatry interview. Patients with mild (N=21) and severe Health anxiety (N=81) and
Hypochondriasis according to the DSM-IV (N=59) were compared with a comparison group of patients who had a well-
defined medical condition according to their FPs and a low score on the screening questionnaire (N=968). Self-rated health
was measured by questionnaire at index and at three, 12, and 24 months, and health care use was extracted from patient
registers. Compared with the 968 patients with well-defined medical conditions, the 81 severe Health anxiety patients and
the 59 DSM-IV Hypochondriasis patients continued during follow-up to manifest significantly more Health anxiety
(Whiteley-7 scale). They also continued to have significantly worse self-rated functioning related to physical and mental
health (component scores of the SF-36). The severe Health anxiety patients used about 41–78% more health care per year in
total, both during the 3 years preceding inclusion and during follow-up, whereas the DSM-IV Hypochondriasis patients did
not have statistically significantly higher total use. A poor outcome of Health anxiety was not explained by comorbid
depression, anxiety disorder or well-defined medical condition. Patients with mild Health anxiety did not have a worse
outcome on physical health and incurred significantly less health care costs than the group of patients with a well-defined
medical condition.
Conclusions/Significance: Severe Health anxiety was found to be a disturbing and persistent condition. It is costly for the
health care system and must be taken seriously, i.e. diagnosed and treated. This study supports the validity of recently
introduced new criteria for Health anxiety.
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Introduction
Hypochondriasis is a rarely used diagnosis in clinical practice
despite studies having reported prevalence between 0.8–9.5% in
primary care [1–3]. This may be because the disorder is not taken
seriously but rather is viewed as an imaginary illness or a
phenomenon secondary to another psychiatric disorder [4,5].
Hypochondriasis is also considered a stigmatizing label, and the
designation ‘Health anxiety’ has been suggested as replacement
and is used in this paper.
There is some evidence that numerous somatic symptoms or
illness worry may be associated with impairment and high health
care utilization [3,6–14]. However, most studies have used self-
reported questionnaires and/or layman interviews on the basis of
which clinical diagnoses cannot be established. Also, with a few
exceptions, the studies are retrospective in design, and comorbidity
with other mental or physical disorders has not been taken into
account. We are not aware of any longitudinal studies on health
care costs or self-rated health that followed up patients with a
Hypochondriasis diagnosis according to Diagnostic and Statistical
Manual (DSM-IV) or International Classification of Diseases
(ICD-10). Relatively little is thus known about Hypochondriasis’
impact on self-rated functioning related to mental and physical
health and longitudinal outcome [15–17].
The lack of valid, reliable, and generally accepted diagnostic
criteria has been a major obstacle in clinical practice and
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9873Hypochondriasis studies [1,4,5,18–20]. Recently, we introduced a
radically revised definition of Hypochondriasis, which we call
Health anxiety to decrease the pejorative connotation. This new
diagnosis is empirically established and has shown to be more valid
than the ICD-10 and DSM-IV definitions, both from a clinical
and a nosological viewpoint [2]. The new diagnostic criteria
include the symptom ‘obsessive rumination about illness’ plus at
least one of the symptoms ‘worry or preoccupation with fears of
harboring an illness or with bodily functions’, ‘suggestibility or
autosuggestibility’, ‘an unrealistic fear of being infected or
contaminated’, ‘an excessive fascination with medical informa-
tion’, or ‘fear of taking prescribed medication’ (Table S1). If the
patient has a comorbid medical condition, the symptoms must not
be accounted for by this. The patients are divided into ‘mild’ and
‘severe’ groups, the latter being characterized by clinically
significant distress or functional impairment [2]. We conducted
a two-year follow-up study of patients with Health anxiety defined
either as fulfilling criteria for DSM-IV Hypochondriasis and/or
the recently introduced empirically established Health anxiety
diagnosis [2] (Table S1). We used the patient sample in which the
new (diagnostic) criteria were developed [2]. We examined the
diagnosis’ clinical importance by assessing its ability to predict
outcome in terms of Health anxiety persistence (Whiteley-7 scale),
the disorder’s impact on self-rated functioning related to mental
and physical health (SF-36 mental and physical component scores
(MCS and PCS)), and health care costs, and we controlled
outcome for the effect of comorbid depression or anxiety disorder.
The outcomes of patients with Health anxiety were compared to
outcomes of patients with a well-defined medical condition.
Methods
Ethics statement
This study was approved by the Science Ethics Committee of
the Central Denmark Region.
We received written informed consent from all the participating
patients.
Patients and setting
This study was based on a randomized controlled trial (RCT)
on the effect of training family physicians (FPs) in treating patients
presenting with medically unexplained symptoms [21]. The study
included 1785 (aged 18–65 years) consecutive patients of
Scandinavian origin consulting their FP during a three-week
period for a new illness problem. 2197 patients, of whom 274
declined the invitation to participate, met the predefined inclusion
and exclusion criteria (exclusion criteria: too ill or demented to
read and fill in questionnaires, exclusively consulting for health
check, or not listed with the practice), and 138 did not participate
for other reasons (Figure 1). The mean age of those declining
participation was 42.2 compared with 38.8 for included partici-
pants (t-test, t (2046)=24.0 p,0.001). There was no significant
gender difference between the two groups. The sociodemographic
characteristics of the sample have been reported elsewhere [2]. All
Figure 1. Flowchart. £ 28 patients both had Health anxiety (severe or mild) and DSM-IV Hypochondriasis. 1 41 of the Health anxiety had a well-
defined medical condition as reason for encounter. To avoid overlap, they were excluded from the medical condition group. * Responses to
questionnaires (Whiteley-7 and SF-36). # DSM-IV Hypochondriasis.
doi:10.1371/journal.pone.0009873.g001
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includes 98% of the Danish population, all individuals being
registered with a specific FP.
Study design and procedures
We used a two-phase design. First, all patients filled in a
screening questionnaire in the waiting room (Figure 1). This
questionnaire included among others the eight-item version of the
Symptom Check List (SCL-8d) [22,23] assessing anxiety and
depression, the seven-item Whiteley scale [24] measuring worrying
and conviction of illness, the somatization subscale of the SCL-90
(SCL-SOM) checking for 12 common physical symptoms [25],
and the Cutting down, Annoyance by Criticism, Guilty feeling,
Eye openers questionnaire (CAGE) which consists of four
questions screening for alcohol abuse [26]. The patients also filled
in the Medical Outcome Study’s Short Form (SF-36) [27].
Patients with a total score of two or more on the SCL-8d, or the
Whiteley-7, or the CAGE, or 4 or more on the SCL-SOM were
selected for the second phase; a diagnostic psychiatric interview.
Furthermore, a random sample of 1/9 of the remaining patients
was selected for interview to produce a stratified subsample
consisting of all high-scorers and 1/9 of the low-scorers. 894
patients were selected for interview, but 193 (21.6%) declined the
invitation. A comparison of the patients declining interview with
the 701 interviewees showed that the former group was composed
of more men, was younger, and had more missing answers on
sociodemographic variables. Fewer from the group declining
interview were employed, were living with a partner, or had an
education beyond basic school compared with the interviewees,
and the former group also had lower scores on the somatic
symptom checklist (SCL-SOM) than interviewees (for details see
[2,28]).
The psychiatric research interview
The psychiatric interviews were conducted as soon as possible
after the index contact, either in the FPs’ clinics, in the research
clinic, or in the patients’ own homes.
Research interviewers used the Schedules for Clinical Assess-
ment in Neuropsychiatry (SCAN) version 2.1 [29,30], which is a
standardized, semi-structured, comprehensive interview endorsed
by the World Health Organization (WHO). It covers all types of
mental disorders. The interview includes an extensive section on
physical health, which is not primarily designed to assess physical
conditions but somatoform and similar disorders. The interview
lasts from 30 minutes in patients with no health problems to
several hours in patients with severe problems. The interviewers
were free to explore external sources of information when they
needed clarification of the interview, for instance by reviewing
medical records. This is helpful if the interview fails to disclose if a
physical complaint is medically unexplained or attributable to a
well-defined medical condition, and it is standard procedure when
using the SCAN. To avoid introducing any bias, the interviewers
were not allowed to request information from the patients’ own
FPs. External information was requested for only few patients.
The section on physical health in the SCAN interview was
extended with additional items on Health anxiety symptoms (for
details see [2]). The SCAN interview requires psychiatric
interviewing skills, and in this study, six psychiatric doctors
certified at the WHO centre in Copenhagen conducted them. An
analysis of eight SCAN interviews which were rated by all six
interviewers showed a high inter-rater agreement on the presence
of/lack of a somatoform diagnosis (kappa=0.82) [28]. Further-
more, five of the six interviewers agreed on a severe Health anxiety
and a DSM-IV Hypochondriasis diagnosis in one patient (one
interviewer did not rate this patient), whereas none of the other
patients were rated as having Health anxiety according to any
criteria. As we did not find disagreement among the interviewers,
we were unable to calculate a Kappa value concerning inter-rater
agreement of Health anxiety. The interviewers were blinded to the
patients’ responses on the screening questionnaires.
FP assessment
After the index consultation, the FPs rated whether the
consultation was due to ‘well-defined medical condition’
(n=1009), ‘probably well-defined medical condition’ (n=395),
‘medically unexplained somatic symptoms’ (n=229), ‘well-defined
mental disorder with somatic symptoms’ (n=95), or ‘no physical
problem’ (n=39). In 18 patients, the FPs had not rated the reason
for encounter.
Follow-up
All patients received a questionnaire by mail at three, 12, and 24
months after the index consultation. The questionnaire included
among other items the Whiteley-7 and the SF-36. Non-completers
received a reminder after two weeks. For both follow-up and index
it was required that patients answered at least 50% of the items in
each scale or index to obtain a score. Otherwise, the score was set
to missing.
Health care costs
The Danish health care system is almost entirely tax financed
and, with a few exceptions, all medical care is free of charge. We
obtained costs of primary and specialized care and psychiatric and
general hospital inpatient and outpatient care from the National
Health Service register in the County of Aarhus from a period of
three years preceding inclusion through two years after inclusion.
Costs of prescribed medicine were obtained from the National
Health Service register in the County of Aarhus for a period of six
months preceding inclusion through two years after inclusion in
the study. Limitations in the Danish law on medicine use
registration prevented us from obtaining retrospective data on
prescribed medicine for a longer period. Costs of lab tests and x-
rays prescribed in primary care were not included.
All costs for inpatient and daytime admissions and outpatient
and emergency ward contacts were extracted from the Danish
National Patient Register and The Danish Psychiatric Central
Register [31]. Non-psychiatric costs were calculated as Diagnosis
Related Group case-mix (DRG) prices by the DRG pricing office
of the Danish National Board of Health in 2004 fixed prices.
Psychiatric hospital care costs were calculated from average 2004
fixed prices for hospital bed days and outpatient contacts with aid
from the economic administration of Psychiatric Hospital in
Aarhus as the hospital is not using DRG prices. All costs were
adjusted for time at risk, and the object for analysis was cost per
year. Index consultation was included in the two years after index.
Comparison with general population sample
We had access to two Danish representative general population
surveys, one on validation of the SF-36 [32], the other on
validation of the SCL-90 [33]. From each of these population
surveys, we constructed a sample matched for age and gender with
the primary care sample.
Data analysis
The SCAN interviews were used for computerized DSM-IV
psychiatric diagnoses, including Hypochondriasis according to
DSM-IV criteria. The section on physical health in the SCAN
Health Anxiety
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anxiety diagnosis.
We compared patients with DSM-IV Hypochondriasis (n=59)
and mild (n=21) and severe (n=81) Health anxiety (Table S1) with
patients having a well-defined medical condition according to the
FPs. 296 of the 1009 patients who according to the FPs consulted
due to a well-defined medical condition were SCAN interviewed,
and the SCAN detected that 41 of those patients also had Health
anxietyorDSM-IV Hypochondriasis.Toavoid inclusion ofpatients
in both the medical condition group and one of the Health anxiety
groups, those 41 patients were only included in one the health
anxiety groups and excluded from the medical conditiongroup, and
therefore this group includes 968 patients in total (Figure 1). 28
patients fulfilled the diagnostic criteria for both DSM-IV Hypo-
chondriasis and Health anxiety (Table 1) [2]. Thus, 133 patients
had Health anxiety or DSM-IV Hypochondriasis. The Whiteley-7
scale is used in different versions in the medical literature, and to
make comparison between different versions easier, we transformed
the scores of the Whiteley-7 into a scale ranging from 0–100 by the
expression (a patient’s actual score–lowest possible score (i.e. 0))/
(Highest possible score (i.e. 28)–lowest possible score (i.e. 0))6100.
The same method was used for the SF-36 questionnaire [34]. As the
study was part of a randomized controlled study on the effect of
training FPs in treating patients presenting with medically
unexplained symptoms [35,36], we controlled for intervention in
the analyses. Group comparison was computed by x
2 tests for
categorical data, and Mann-Whitney U or Kruskal-Wallis test was
used for non-normally distributed continuous data.
We wanted to compare patients with Health anxiety or DSM-
IV Hypochondriasis with patients having a well-defined medical
condition according to their FPs, thereby estimating two models
for each outcome. Inspecting the patients’ individual graphs for
Whiteley-7, PCS, and MCS over time, we worked out that an
appropriate choice of model was a mixed effect model with
random intercept in order to model the mean differences in scores
[37]. The general shape of the model is a group-specific level at
index and a group-specific level, i.e. one level, at the remaining
time points. This was modelled through two variables with a
possible interaction. We included linear adjustment for gender,
age, comorbid major depressive or anxiety disorder, medical
condition, and intervention. A Wald test for interaction between
the Health anxiety diagnosis and either comorbid major depressive
or anxiety disorder was performed. The model was checked by
diagnostic plots of the residuals.
In the lack of general population norms for response on the
Whiteley-7 scale, we arbitrarily set the cutpoint for a normal versus
‘‘ill’’ response equal to the 90 percent percentile at 24-month
follow-up for patients with a well-defined medical condition.
In order to account for skewed health care costs with an excess
of zeros, we have estimated sample means of health care costs with
bias-corrected and accelerated (BCa) 95% confidence intervals.
Test of equality of health care cost means for patients with a
medical condition according to their FP and patients with Health
anxiety were done by computing the bootstrap test statistic
achieved significance level (ASL) [38].
We processed the data in STATA 9 [39].
Results
The diagnostic group characteristics and comorbidity between
diagnoses are shown in Table 1. As 28 patients fulfilled diagnostic
criteria for both Health anxiety and DSM-IV Hypochondriasis,
the combined final sample size was 133, i.e. patients who either
had Health anxiety or DSM-IV Hypochondriasis. Between 24.7
and 33.3% of the patients with Health anxiety according to the
diagnostic interview definitely had a well-defined medical
condition as reason for encounter according to their FPs. The
Health anxiety group comprised more females than the patient
group with a well-defined medical condition. No age difference
was found between groups.
Table 1. Characteristics of the sample.
Health anxiety DSM-IV Hypochondriasis Well-defined
Severe Mild medical cond.*
(a) (b) (c) (d)
Number of patients 81 21 59 968
Females%{ 71.6 61.9 79.6 58.9
Age (mean, SD){ 39.7 13.1 39.1 13.1 38.4 11.3 37.8 13.1
Comorbidity n % n % n % n %
Major depressive episode 14 17.3 1 4.8 9 15.3 9 3.5
Anxiety disorder 29 35.8 1 4.8 25 42.2 20 7.8
Medical condition according to FP
Definitely 20 24.7 7 33.3 19 32.2 -
Probably 22 27.2 6 28.6 13 22.0 -
DSM-IV Hypochondriasis 25 30.9 3 14.3 - - - -
Health anxiety
Mild - - - - 3 5.1 - -
Severe - - - - 25 42.4 - -
*The FPs rated definitely well-defined medical conditon as reason for encounter at index and the patients had no Health anxiety at diagnostic interview.
{x2 test: Health anxiety (a,b) vs medical condition (d) x2=5.1, p=0.079, df=2, DSM-IV hypochondriasis vs medical condition c2=10.0, p=0.002, df=1.
{: Health anxiety (a,b) vs medical condition (d), Kruskal-Wallis test: x2=2.0, p=0.3683, df=2, DSM-IV Hypochondriasis vs medical condition, Mann-Whitney test,
Z=20.75, p=0.456.
doi:10.1371/journal.pone.0009873.t001
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Table 2. The highest number lost to follow-up was in the DSM-IV
Hypochondriasis group in which only 66% answered the 24-
month follow-up questionnaire. At least 78% of the patients with
severe Health anxiety completed the questionnaire, in the mild
Health anxiety group 87% or more did, and in the medical
condition group 72% or more answered the follow-up question-
naire. There were no statistically significant differences in White-
ley-7 scores at index consultation between patients completing the
questionnaires and patients declining to complete at any follow-up
times (Mann-Whitney U test, p.0.086 or higher) (details available
from the authors on request).
The results from the two mixed effect models for Whiteley-7 are
shown in Table 3 and Figure 2. The scores of both the severe and
mild Health anxiety and the DSM-IV Hypochondriasis patients
were statistically significantly higher than the scores for the
patients with a well-defined medical condition according to the
FPs at index consultation. Health anxiety scores dropped
significantly from index consultation to later follow-up in all
diagnostic groups. At later follow-up times, the Whiteley-7 scores
remained at a statistically significantly higher level in the severe
Health anxiety and the DSM-IV Hypochondriasis patients
compared with patients with a well-defined medical condition,
whereas there were no statistically significant differences between
the mild Health anxiety patients and those with a well-defined
medical condition (Table 3 and Figure 2). We tested for interaction
with comorbid major depressive and anxiety disorder, but none
were statistically significant.
Table 2 also displays the percentage of patients scoring above
21.5 on the Whiteley-7 scale. It is seen that 45.3% of the patients
with severe Health anxiety would still be ill at 24 months using this
cutpoint for an ‘‘ill’’ response. However, it has to be noticed that
only 59.3% of the Health anxiety patients scored above this
cutpoint at the index consultation and thus the fraction of patients
above the cutpoint score seems quite stable in that very few Health
anxiety patients seem to get well.
The PCS and MSC scores appear from Table 4. Patients with
mild Health anxiety and patients with a well-defined medical
condition had scores similar to the age and gender matched
general population sample. Some patients were lost to follow-up;
the highest number in the well-defined medical condition group in
which only 60% answered the 24-month follow-up questionnaire,
whereas 66% or more of the DSM-IV Hypochondriasis patients,
65% or more of the severe Health anxiety, and at least 76% of the
mild Health anxiety patients completed the follow-up question-
naire. There were no statistically significant (p.0.36, Mann-
Whitney U test) differences in PCS or MCS scores at index
between patients completing the questionnaires and non-com-
pleters, nor at any of the follow-up periods.
The results from the two mixed effect models for PCS mean
scores are provided in Table 3. All diagnostic groups had
statistically significant improvements in PCS scores from index
to later follow-up times. The differences in PCS scores between the
severe Health anxiety patients, the DSM-IV Hypochondriasis
patients, and the well-defined medical condition patients were
statistically significant (Table 3). We found no statistically
significant interactions with comorbid major depressive and
anxiety disorders and the Health anxiety and DSM-IV diagnoses.
Functioning related to mental health did not improve
significantly over time in the mild and severe Health anxiety
patients, whereas the DSM-IV Hypochondriasis patients im-
proved statistically significantly after the index consultation
(Table 3 and Figure 3). Patients with severe Health anxiety and
DSM-IV Hypochondriasis had significantly lower MCS scores at
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PLoS ONE | www.plosone.org 6 March 2010 | Volume 5 | Issue 3 | e9873three-month follow-up compared with the well-defined medical
condition patients. Test for interaction of comorbid major
depressive and anxiety disorders revealed statistical significance
between DSM-IV Hypochondriasis and major depressive episode
(Wald test, x(1)=4.79, p=0.029). A comorbid major depressive
episode had a more severe impact on patients with a well-
defined medical condition than on patients with DSM-IV
Hypochondriasis.
The diagnostic plots of the residuals were examined for the six
models presented in Figure 2, 3, and Table 3, and no critical
departure from the model stated normal distributions was seen.
Health care utilization
The overall health care costs and use of primary care for the
period of three years preceding the index consultation through two
years after index was quite constant for all patient groups (data not
shown). The mean health care costs per year in Euro appear from
Table 5. Overall, the severe Health anxiety patients used about
41–78% more health care services, excluding laboratory tests and
x-rays prescribed in primary care, per year than patients with a
well-defined medical condition, both before and after the
encounter in primary care. The former group’s use was statistically
significantly different from that of the latter group for all types of
health care use displayed in Table 5, except for general hospital
and psychiatric care after the index consultation. The DSM-IV
Hypochondriasis patients had a significantly higher use of primary
care compared with the well-defined medical condition patients,
whereas there were no statistically significant differences as to the
other types of use displayed in Table 5. The medicine
reimbursement stemming from psychoactive drugs accounted for
22% in patients with a well-defined medical condition and 38% in
patients with severe Health anxiety or DSM-IV Hypochondriasis
(results not shown). Contrary to patients with severe Health
anxiety, patients with mild Health anxiety use significantly less
health care than patients with a well-defined medical condition.
Discussion
This study suggests that Health anxiety in its severe form has
significant long-term impact on the patients’ self-rated functioning
related to mental and physical health and on health care costs, and
the patients persistently report high levels of Health anxiety
measured on Whiteley-7. Health anxiety in its mild form,
however, seems not to have any significant negative impact on
physical health and health care costs.
We used two definitions of ‘‘caseness’’: the DSM-IV Hypo-
chondriasis criteria and the newly introduced empirically estab-
lished criteria for Health anxiety [2]. Among other points of
critique, the DSM-IV Hypochondriasis diagnosis has been
criticized for being poorly and arbitrarily defined overlapping
with other somatoform and psychiatric disorders [1,4,5,19,20]. In
an earlier study based on the same patient sample as the present
one, we showed that the recently defined diagnosis overcomes
many of the drawbacks of the current DSM-IV diagnosis [2]. It is
based on positive identification instead of exclusion of physical
disease and is easy to use in clinical practice [2]. An important
validation criterion for a diagnosis is its ability to predict outcome
and to identify patients in need of treatment [40]. This study shows
that the new, empirically established Health anxiety diagnosis
identified a patient group with an unfavorable outcome.
Furthermore, the severe Health anxiety patients used significantly
more overall health care than patients with a well-defined medical
condition, whereas this was not the case for DSM-IV Hypochon-
driasis patients. This finding is remarkable, as the DSM-IV
criteria, contrary to the new criteria, require illness duration of
least 6 months. Patients fulfilling the DSM-IV criteria thus ought
to be more chronically ill. Furthermore, the DSM-IV criteria
identified fewer patients than the new criteria for severe Health
anxiety. This would usually indicate that the DSM-IV criteria
identify more severely ill patients, but the results of this study
showed that this was not the case. We did not find any differences
Figure 2. Health anxiety during follow-up according to mixed effect model with a random intercept. * Corrected for age, gender,
comorbid anxiety disorder, or major depression, medical condition and intervention. ** Statistics displayed in Table 3. Health anxiety and DSM-IV
Hypochondriasis were tested in two separate statistical models, and the expected values for the medical condition groups were not identical despite
including the same individuals. Model 1 is for Health anxiety vs medical condition including 1066 patients with 3393 scores, model 2 is DSM-IV
Hypochondriasis vs medical condition including 1024 patients with 3237 scores.
doi:10.1371/journal.pone.0009873.g002
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PLoS ONE | www.plosone.org 8 March 2010 | Volume 5 | Issue 3 | e9873in outcomes between patients with DSM-IV Hypochondriasis
only, patients with severe Health anxiety only, and patients with
both diagnoses. We did not test the difference in mean cost
between Health anxiety and DSM-IV Hypochondriasis directly.
These findings favor the validity of the new diagnostic construct.
However, it has to be acknowledged that the validity of the new
criteria has not yet been confirmed in independent populations.
We showed a fall in Health anxiety scores on the Whiteley-7
scale from index to later follow-up times for all patient groups.
Whether they also had elevated scores prior to the consultation is
unknown, but studies have indicated that high illness worry
initiates help-seeking behavior [41,42]. Thus, the patients may
actually have been reassured by their doctor, but the Health
anxiety patients were only partially reassured as they continued to
have much higher Health anxiety scores after the consultation
than patients with a well-defined medical condition. This is in line
with the study of Lucock et al [43] who showed that the effect of
reassurance after gastroscopy showing no serious illness was only
temporary in patients with a pre-examination high level of Health
anxiety.
The persistence of Health anxiety, which in this study was
indicated by the high Health anxiety follow-up scores on the
Whiteley-7 scale, seems to be in accordance with other studies
reporting that many patients still fulfilled diagnostic criteria for
Hypochondriasis during the follow-up period [15,17]. To our
knowledge, our study is the first to examine other longitudinal
outcome measures than diagnoses.
Impact of comorbidity on outcome
We have controlled for comorbid depression or anxiety disorder
in the analyses. The poor outcomes for patients with Health
anxiety or DSM-IV Hypochondriasis could not be explained by a
comorbid mental disorder. The association between Health
anxiety and unfavorable outcome may be explained by the
possibility that patients with a well-defined medical condition are
more inclined to fear for their health and therefore mistakenly may
appear to have Health anxiety. However, we also adjusted for a
comorbid medical condition according to the FPs, and we did not
find that this had impact on outcome in the Health anxiety
patients.
It is noteworthy that the severe Health anxiety patients had
worse outcomes on any outcome measures used in this study,
including PCS, than patients with a well-defined medical
condition. The patients with severe Health anxiety scored from
6.0 to 7.2 lower on the PCS and from 8.8 to 12.6 lower on the
MCS (unadjusted scores Table 4) compared with the medical
condition patients and the general population sample. Such a
difference is usually considered clinically significant, and for the
MCS, the difference exceeded one SD. The MCS scores are below
the scores for most disorders or diseases for which figures are
available except for depression [27], and they are in particular
much lower than reported in studies on Somatization disorder
[44]. Health anxiety patients had worse or similar PCS scores than
reported in studies on cancer, lower back pain, diabetes, and
Somatization disorder patients but not quite as low as reported in
rheumatoid arthritis and lung disease patients [27,44]. We showed
an improvement in PCS scores at later follow-up in Health anxiety
as opposed to Dickinson et al [44] who showed a decrease in
Somatization disorder patients.
We chose to include a control group consisting of patients,
whom according to the FPs primarily consulted due to medically
well-defined physical conditions. This choice offered the oppor-
tunity to compare the outcomes in Health anxiety patients with the
outcomes in patients, who, for the major part, did not have a
mental illness or a chronic medical condition and who did not
consult due to medically unexplained symptoms. However, the
control group was not representative of the primary care
population as such as a large segment of patients likely to generate
high health care costs and show great impairment was excluded.
Thus, we only included about half of the patients approached for
Figure 3. Mental component summary score during follow-up according to mixed effect model with a random intercept. * Corrected
for age, gender, comorbid anxiety disorder, or major depression, medical condition and intervention. ** Statistics displayed in Table 3. Health anxiety
and DSM-IV Hypochondriasis were tested in two separate statistical models, and the expected values for the medical condition groups were not
identical despite including the same individuals. Model 1 is for Health anxiety vs medical condition including 984 patients with 3042 scores, model 2
is DSM-IV Hypochondriasis vs medical condition including 944 patients with 2910 scores.
doi:10.1371/journal.pone.0009873.g003
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of choosing this comparison group may be questioned as may the
choice of any comparison group. The patients with a well-defined
medical condition are a very heterogeneous group including
patients with severe physical disease and patients consulting for
minor or transient ailments, e.g. flu. Despite this, it is a more
homogeneous group than the overall group of all patients
consulting their FP, and we feel that using this group for
longitudinal comparison makes sense and provides transparency.
We also included an age and gender matched general population
sample for comparison, but since we do not have follow-up data
on this cohort, we could not use it for longitudinal comparison.
Still, our choice of comparison group provides a notion of the
primary care representatives and the Danish population compared
with other countries. It would be interesting to compare the
outcomes in patients with depression, anxiety, medically unex-
plained symptoms or other somatoform disorders and patients
with chronic medical conditions with the outcomes of Health
anxiety patients, but this calls for another study with focus on this
comparison, and it is beyond the scope of the present paper.
Strengths and limitations
A limitation of the study is the response rate at follow-up in
some of the patient groups. The lowest response rates at two-year
follow-up were in the DSM-IV Hypochondriasis group, in which
66% responded to the Whiteley-7 questionnaire and in the
medical condition group in which 60% responded to the SF-36.
The response rate was higher at all time points in all of the other
patient groups. We did not detect any statistically significant
differences between completers and non-completers of the follow-
up questionnaire, and hence we do not expect any systematic bias
as to non-completers. A strength of the study is that we had
complete health care utilization data for all patients as the data
were obtained from patient registers.
A major strength of this study is that the Health anxiety/
Hypochondriasis diagnoses are based on the state of the art SCAN
interview performed by psychiatrically trained physicians. How-
ever, we only interviewed a stratified sample of 701 patients of
which 296 had either a Hypochondriasis/Health anxiety diagnosis
or a well-defined medical condition according to their FPs. This
means that some of the patients in the well-defined medical
condition group were not interviewed, because they had low scores
on the screening questionnaire and were not randomly selected for
interview. Some of these non-interviewees may therefore have had
undetected Health anxiety, and we estimate that approximately 29
patients did, which entails a misclassification bias. These 29
patients ought to have low scores on illness worry, and/or high
self-rated health, and/or low use of health care for a differential
misclassification bias to be present. We find it very unlikely that a
patient with severe Health anxiety, and thus with symptoms that
severely disturb or significantly interfere with everyday activities,
has low illness worry, and/or high self-rated health, and/or low
health care costs. We therefore assess that a misclassification bias
would be of a non-differential type.
This study was a part of an RCT intervention study on medically
unexplained symptoms and somatoform disorders in primary care
[35,36]. The intervention did not specifically address treatment of
Health anxiety. Thus, we did not find any clinically or statistically
significant treatment effects. Although insignificant, we cannot
completely rule out that the outcomes may have been better as a
result of the doctors’ training and the intensive focus on the subject
inthe studyperiodthusperhaps resultingina biastowardsanoverly
optimistic outcome. The FPs judged that about half of the Health
anxiety patients attended either definitely or probably due to a
medical condition. This indicates that the FPs need better
procedures for identifying patients with Health anxiety, although
we cannot conclude this for certain. Patients with Health anxiety
may have consulted their FP due to a comorbid physical condition,
and we did not register the primary reason for the consultation
when a patient had more than one illness.
Another limitation of the study is that we did not re-examine the
patients by means of the SCAN interview at follow-up as the
follow-up was based solely on self-reported questionnaires (the SF-
36 and the Whiteley-7) and health care costs from patient registers.
Therefore, we do not know if any patients had developed another
physical or mental disorder that may have influenced the outcome,
for example whether part of the increase in health care costs may
be attributable to an instable medical condition that surfaced after
inclusion in the study. We also do not know if the patients still
fulfilled the diagnostic criteria for Hypochondriasis after two years.
A previous report has found that two thirds continued to meet
DSM-IV criteria for Hypochondriasis after one year [17]. Another
study found that 63% still met the criteria four to five years later
[45]. We realize that continued fulfilment of the diagnostic criteria
is an important outcome measure, and it is a limitation of this
study that we only have self-reported Health anxiety at follow-up
instead of new diagnostic interviews. However, we believe that
prediction of outcome in the form of disability, subjective suffering,
and health care costs may be more relevant outcome measures
than patients fulfilling diagnostic criteria at follow-up. The mild
Health anxiety diagnosis seems to have only a small impact on
outcome. The mild Health anxiety patients’ physical component
scores were at most time points similar to those of the medical
condition group, and their health care costs compared with the
medical condition group were significantly lower both before and
after index indicating a good outcome. Mild Health anxiety does
thus not seem to be a precursor of severe Health anxiety. This is in
accordance with the results of Barsky et al [16], who found that
only one out of 24 patients with transient Hypochondriasis (i.e.
Hypochondriasis with a duration of less than 6 months) developed
Hypochondriasis according to DSM-III-R criteria at averagely 22-
month follow-up. However, due to the small number of patients
with mild Health anxiety, the outcome for this group should be
taken with some reservation, in particular as to costs.
In the statistical analyses, we did not correct for multiple testing.
Conclusions and implications
Health anxiety seems in its severe form to be a quite disturbing
and persistent condition entailing high health care costs, and it
should be more consistently diagnosed and aggressively treated.
Studies now indicate that the condition can be treated effectively
by specialists [46,47]. However, as Health anxiety is very prevalent
it is important that also FPs and other physicians achieve basic
skills in treating and identifying the disorder. If patients’ health
worries are addressed at an early stage by the physicians, repeated
consultations and medical examinations may be prevented, and it
could also prevent development of more severe Health anxiety
that needs intensive intervention.
This study adds further support to the validity of the recently
introduced new criteria for severe Health anxiety, whereas the
mild Health anxiety group may be less clinically relevant as these
patients have a better outcome.
Supporting Information
Table S1 Suggested diagnostic criteria for Hypochondriasis.
Found at: doi:10.1371/journal.pone.0009873.s001 (0.03 MB
DOC)
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